• April 7, 2014

    IDIBAPS researchers identified a new neurodegenerative disease related to sleep disorders

    Discover how the brain, memory, or what tools works allow you to  identify behavioral disorders are some of the challenges facing the  neuroimmunology, a science that studies the inflammation and  mechanisms of inflammation of the central nervous system and its  involvement in diseases such as multiple sclerosis, autoimmune  encephalitis or paraneoplastic neurological diseases. Dr. Josep  Dalmau,  IDIBAPS ICREA researcher who leads the IDIBAPS  Autoimmunity against synaptic antigens Group, is an international  leader in the study of neurology  and psychiatry and in the past 7 years  has identified a total of 8  inflammatory brain diseases. The Lancet  Neurology published an article  last week with another of his  discoveries , a neurodegenerative disease  related to sleep disturbances  hitherto unknown. Dr. Francesc Graus,  leader of Clinical and experimental neuroimmunology IDIBAPS Group and head of the Neurology at Hospital Clinic in Barcelona, is the principal investigator of the recent publication, in which also participated Dr. Joan Santamaria, neurologist Unit Sleep disorders Clinic, among others. This study has also been possible thanks to the participation of the Neurological Tissue Bank Hospital Clínic -IDIBAPS Biobank.

    Read the rest of this entry

  • March 20, 2014

    IDIBAPS welcomes the third meeting of COST Action BM1206 for genetic studies of colorectal cancer

    Colorectal cancer (CRC) is one of the most frequent neoplasms worldwide and an important cause of morbidity in the developed world. It is necessary to identify individuals with a medium-high CRC risk in order to develop adequate preventive measures. The identification of inherited genetic factors involved in CRC susceptibility can help to profile individual disease risk and may enable early screening and treatment monitoring. COST Action BM1206 leaded from IDIBAPS by Sergi Castellví-Bel includes nowadays 98 participants from 22 countries actively working on CRC genetics. This Action will permit to comprehensively understand the impact of inherited susceptibility to CRC and to describe the genetic landscape of this disease, providing a highly innovative and unconditional tool for personalized CRC medicine with a future application in early screening and treatment monitoring for this disease.

    Read the rest of this entry

  • March 12, 2014

    IDIBAPS organize workshop on Translational Genomics in Biomedicine

     Next 13th and 14th March IDIBAPS organizes Translational Genomics  in Biomedicine workshop in Barcelona, a meeting led by Sergi    Castellví Bell, Meritxell Gironella, Cristina Fillat, Silvia Beà     and Luis Hernández, which aims to bring together international leaders in translational genomics applied to biomedicine.

    For two days will be offered examples of the progress achieved in this field in diseases such as cancer, diabetes, hepatitis, and rare diseases. The main goal of translational research is to discover genomic diagnostic tools and innovative treatments for human genetic diseases and optimize patient health care and preventive measures. For more information you can access the program at the following link.

  • March 12, 2014

    Dr. Pere Ginès leads a Position Paper on Bacterial Infections in Cirrhosis

     Journal of Hepatology, the official journal of the European Association for the Study of  the Liver (EASL), publishes a Position Paper on Bacterial Infections in Cirrhosis.  Bacterial infections are one of the most common complications of cirrhosis and  represent an important reason for hospital admission and one of the leading causes of  death in this disease. The document that has been just published represents a joint effort  of 25 worldwide experts in the field that gathered for an EASL Special Conference held in  Barcelona in May 2013. The document is led by Dr. Pere Ginès, chairman of the Liver Unit of the Hospital  Clínic, full professor of the University of Barcelona, and leader of the  research group on  “Mechanisms of Liver Diseases and Complications of Cirrhosis” of the  IDIBAPS and Dr.  Rajiv Jalan from the Royal Free Hospital in London. The document  also includes  other members of the Liver Unit of the Hospital Clínic, Dr. Javier  Fernández and Dr.  Vicente Arroyo, and Dr. Jordi Vila, chairman of the Microbiology  Unit of the Hospital  Clínic. The document can be found here.

  • March 5, 2014

    IDIBAPS creates Transplant Biotech, a spin off company for innovation in medical devices related to organ transplantation, metabolic, liver and kidney diseases

     On  Monday 3th of March it was celebrated the establishment of  Transplant Biotech S.L., the first spin -off 100 % IDIBAPS led by  IDIBAPS's researchers: Dr. Carmen Peralta, an expert in therapeutic  strategies in ischemia - reperfusion, with Dr. Anna Novials, expert in  diabetes, and Dr. Jordi Gracia, a specialist in vascular biology. The participation of Dr. Peralta in BioEmprenedorXXI program, an  initiative of Biocat, la Caixa and Barcelona Activa, with the goal of  supporting entrepreneurship in the field of biotechnology and  biomedicine, has enabled the translation of a project research in a  business plan. Thanks to Dr. Josep Lluís Falco, project tutor assigned by the program, the research team was able to develop a business plan for innovation in medical devices related to organ transplantation, metabolic, liver and kidney disease. The process has had the full support and backing IDIBAPS, the institution where the research and intellectual property of the project have been made. In addition, it has had the involvement of Mr. Ignasi Heras innovation expert and business development. Photo (left to right): Mr. Ignasi Heras, Dr. Ramon Gomis (IDIBAPS director), Dr. Carmen Peralta, Dr. Josep Lluís Falcó, Dr.Jordi Gracia and Dr. Anna Novials.